of Work: Improved understanding of the structure of HIV proteins can be useful in unraveling the function of the proteins and in understanding the mechanisms of the function of these proteins. This structural knowledge can also be useful in designing novel anti-HIV agents. X-Ray crystallography is the most accurate technique for determination of protein structures. Major drawbacks of the technique, however, are that it can be very time consuming and is dependent on the availability of protein crystals. Molecular modeling programs, on the other hand, can provide insights into the protein structure based on, amongst other things, homology with proteins whose structures are known. Although this approach is attractive, the results have often been less reliable than desired because insufficient information about the protein is available or the degree of homology with proteins of known structure is less than needed for the development of an accurate model. Furthermore, many proteins are posttranslationally modified. These modifications can regulate the activity of the protein, alter the tertiary structure of the protein, or alter the interactions of the protein. Thus, it is important to determine these posttranslational modifications. HIV gp120 is highly posttranslationally modified by glycosylation. We have previously identified the types of glycans observed at specific glycosylation sites and have noted that high mannose glycans and complex glycans tend to be segregated on the surface of the molecule. We were not able, however, to determine the extent of silylation of the complex glycans. We are currently investigating the use of a combination of carbohydrate affinity chromatography to concentrate the glycosylated tryptic fragments of gp120 followed by LC/MS/MS analysis to determine the extent of silylation of specific consensus glycosylation sites. We are also currently growing cell cultures that express the chemokine receptor CXCR4. We will undertake extensive structural studies of the isolated CXCR4 as well as using it in our receptor-ligand studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES050150-07
Application #
6673003
Study Section
(LSB)
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2002
Total Cost
Indirect Cost
Name
U.S. National Inst of Environ Hlth Scis
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Dhungana, Suraj; Williams, Jason G; Fessler, Michael B et al. (2009) Epitope mapping by proteolysis of antigen-antibody complexes. Methods Mol Biol 524:87-101
Robinette, David; Neamati, Nouri; Tomer, Kenneth B et al. (2006) Photoaffinity labeling combined with mass spectrometric approaches as a tool for structural proteomics. Expert Rev Proteomics 3:399-408
Williams, Jason G; Tomer, Kenneth B; Hioe, Catarina E et al. (2006) The antigenic determinants on HIV p24 for CD4+ T cell inhibiting antibodies as determined by limited proteolysis, chemical modification, and mass spectrometry. J Am Soc Mass Spectrom 17:1560-9
Hager-Braun, Christine; Katinger, Hermann; Tomer, Kenneth B (2006) The HIV-neutralizing monoclonal antibody 4E10 recognizes N-terminal sequences on the native antigen. J Immunol 176:7471-81
Hager-Braun, Christine; Tomer, Kenneth B (2005) Determination of protein-derived epitopes by mass spectrometry. Expert Rev Proteomics 2:745-56
Hager-Braun, Christine; Tomer, Kenneth B (2004) Determination of epitopes by mass spectrometry. Methods Mol Med 94:109-20
Cutalo, Jenny M; Deterding, Leesa J; Tomer, Kenneth B (2004) Characterization of glycopeptides from HIV-I(SF2) gp120 by liquid chromatography mass spectrometry. J Am Soc Mass Spectrom 15:1545-55
Hager-Braun, Christine; Tomer, Kenneth B (2002) Characterization of the tertiary structure of soluble CD4 bound to glycosylated full-length HIVgp120 by chemical modification of arginine residues and mass spectrometric analysis. Biochemistry 41:1759-66
Parker, C E; Tomer, K B (2000) Epitope mapping by a combination of epitope excision and MALDI-MS. Methods Mol Biol 146:185-201
Hochleitner, E O; Borchers, C; Parker, C et al. (2000) Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysis. Protein Sci 9:487-96

Showing the most recent 10 out of 13 publications